PRESS RELEASE published on 01/31/2024 at 18:09, 2 years 9 months ago AltaThera Pharmaceuticals at AF Symposium 2024 AltaThera Pharmaceuticals will present data on Sotalol IV, a treatment that may significantly shorten hospital stays for heart-related illnesses at the 29th Annual AF Symposium in Boston from February 1-3. The presentation will feature insights from the PEAKS Registry by Dr. T. Jared Bunch, an esteemed figure in the field of electrophysiology AF Symposium Electrophysiology AltaThera Pharmaceuticals Sotalol IV Hospital Stays
Published on 11/05/2026 at 15:20, 12 minutes ago MicroVision and LAKE FUSION Technologies Sign Multi-Year Strategic Partnership Agreement for IRIS(TM) Lidar Sensors
Published on 11/05/2026 at 14:31, 1 hour 1 minute ago First Breach Close-Quarters Strike (CQS) Drone Successfully Completes Full Mission Profile
Published on 11/05/2026 at 14:25, 1 hour 7 minutes ago Polaris Renewable Energy Announces Q3 2026 Results
Published on 11/05/2026 at 14:20, 1 hour 12 minutes ago Polaris Renewable Energy Declares Quarterly Dividend
Published on 11/05/2026 at 14:15, 1 hour 17 minutes ago Loar Holdings Inc. Reports Q3 2026 Record Results and Upward Revision to 2026 Outlook and Full Year 2027 Outlook
Published on 11/05/2026 at 15:10, 22 minutes ago Center for Creative Leadership Names Patrick Mullane President and Chief Executive Officer
Published on 11/05/2026 at 14:58, 34 minutes ago Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 11/05/2026 at 15:01, 30 minutes ago Chiffre d'Affaires du 1er semestre de l'exercice 2026/2027
Published on 11/05/2026 at 10:16, 5 hours 15 minutes ago Accélération confirmée au troisième trimestre 2026 Tous les métiers en croissance, chiffre d’affaires en progression de +6,5 %
Published on 11/05/2026 at 10:16, 5 hours 15 minutes ago Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%